LAS VEGAS, May 24, 2021 /PRNewswire/ -- JetBlack Corp. (OTC: JTBK) the "company" or "JetBlack" recently announced many updates regarding its subsidiaries. The Indica Company created distribution partnerships with overseas manufacturers of cannabis accessories, which will allow the company to begin wholesale operations. Revenues were generated last quarter, while still low, gross revenues rose 375% from the previous quarter. Rubens AI launched a bold ambitious project to develop automated modular farming solutions which would be used in exo-earth applications. CenAviv is expecting to have in its seed bank over 2000 varieties of non-commercial, commercial, and rare plant varieties by the end of the second quarter. EndoCleanse™, Ensys Health's flagship product is eagerly anticipated. In addition, Jetblack is in negotiations with Black Rose Organics (BRO) to reach a mutually beneficial definitive agreement which would circle around BRO's expansion initiatives.
More information on JTBK can be found at www.JetblackCorp.com and the company official twitter account@jetblackcorp
Disclaimer:
This press release should not in any way be misunderstood as an offer to sell securities or solicitation to sell securities. This press release contains forward-looking statements. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as "believe," "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially fromthose expressed or implied by such forward-looking statements. These factors, risks, and uncertainties include market risks associated with our business, the inability to raise enough capital to complete our business, economic conditions, and increasing competition. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's and management control which could, and likely will materially affect actual results, levels of activity, performance or achievements. Investors should be cautioned that nine out of ten start-ups and small businesses fail. If the company cannot achieve financing, then it may not be able to follow through with its business plan. This may lead to an investor losing part or their entire investment. Investors may have trouble locating a broker-dealer to trade their stock. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The loss of key employees would be detrimental to the company's success and may cause failure. Currently, the company is considered a penny stock, the spreads can be very far apart, sometimes illiquid, and investors may not be able to sell when they want or for the price they paid. In some circumstances, the investor may lose all their investment. This press release is not an offer to sell securities. This press release should not be interpreted or misunderstood as an offer or solicitation to sell securities. Investors should also be cautioned that Covid-19, viruses, pandemics, diseases, also present serious challenges for business operations. Investors should note, these uncontrollable circumstances could potentially lead an investor to lose their entire investment very quickly.
Source:
Jetblack Corp. IR department
[email protected]
twitter.com/Jetblackcorp
888-611-5825
SOURCE JetBlack Corp.
Share this article